1. ScholarBank@NUS

Shao Peng, David Tan

rp27124

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Shao Peng, David Tan
Variants
Tan, David S.P.
 
Main Affiliation
 
Faculty
 
Email
mdctspd@nus.edu.sg
 
Other emails
 

Publications

Results 21-30 of 30 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
211-Jun-2022Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast CancerLim, JSJ ; Wong, ALA ; Ow, SGW ; Ngoi, NYL ; Chan, GHJ; Ang, YLE; Chong, WQ; Lim, SE ; Lim, YW; Lee, M; Choo, JRE; Tan, HL; Yong, WP ; Soo, RA ; Tan, DSP ; Chee, CE ; Sundar, R ; Yadav, K ; Jain, S ; Wang, L ; Tai, BC ; Goh, BC ; Lee, SC 
2224-Sep-2021Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine InitiativesJain, Sneha Rajiv; Sim, Wilson; Ng, Cheng Han; Chin, Yip Han; Lim, Wen Hui; Syn, Nicholas L.; Kamal, Nur Haidah Bte Ahmad; Gupta, Mehek; Heong, Valerie; Lee, Xiao Wen; Sapari, Nur Sabrina ; Koh, Xue Qing; Isa, Zul Fazreen Adam ; Ho, Lucius; O’Hara, Caitlin; Ulagapan, Arvindh; Gu, Shi Yu; Shroff, Kashyap; Weng, Rei Chern; Lim, Joey S. Y.; Lim, Diana ; Pang, Brendan ; Ng, Lai Kuan ; Wong, Andrea ; Soo, Ross Andrew ; Yong, Wei Peng ; Chee, Cheng Ean; Lee, Soo-Chin ; Goh, Boon-Cher ; Soong, Richie ; Tan, David S. P. 
23Jun-2021Targeting the replication stress response through synthetic lethal strategies in cancer medicineNgoi, Natalie YL ; Pham, Melissa M; Tan, David SP ; Yap, Timothy A 
242023The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancerYeo, Xun Hui; Sundararajan, Vignesh ; Wu, Zhengwei ; Phua, Zi Jin Cheryl; Ho, Yin Ying; Peh, Kai Lay Esther; Chiu, Yi-Chia; Tan, Tuan Zea ; Kappei, Dennis ; Ho, Ying Swan; Tan, David Shao Peng ; Tam, Wai Leong ; Huang, Ruby Yun-Ju 
25Jun-2021The role of homologous recombination deficiency testing in ovarian cancer and its clinical implications: do we need it?Ngoi, NYL; Tan, DSP 
26Mar-2021The systemic treatment of recurrent ovarian cancer revisitedBaert, T; Ferrero, A; Sehouli, J; O'Donnell, DM; González-Martín, A; Joly, F; van der Velden, J; Blecharz, P; Tan, DSP ; Querleu, D; Colombo, N; du Bois, A; Ledermann, JA
271-Dec-2023Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4Kim, YN; Park, B; Kim, JW; Kim, BG; Kim, SW; Kim, HS; Choi, CH; Lim, MC; YL Ngoi, N ; SP Tan, D ; Lee, JY
282017Understanding resistance mechanisms and expanding the therapeutic utility of PARP inhibitorsLim, J.S.J ; Tan, D.S.P 
92018Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) StudyHeong V.; Syn N.L.; Lee X.W.; Sapari N.S. ; Koh X.Q.; Adam Isa Z.F. ; Sy Lim J.; Lim D. ; Pang B. ; Thian Y.L. ; Ng L.K. ; Wong A.L. ; Soo R.A. ; Yong W.P. ; Chee C.E. ; Lee S.-C., Goh B.-C. ; Soong R. ; Tan D.S.P. 
102020Whole exome sequencing of multi-regional biopsies from metastatic lesions to evaluate actionable truncal mutations using a single-pass percutaneous techniqueHeong V.; Tay D.; Goh S.E. ; Wee B. ; Tan T.Z. ; Soo R. ; Pang B. ; Lim D. ; Gopinathan A. ; Ow S. ; Chee C.E. ; Goh B.C. ; Lee S.C. ; Yong W.P. ; Wong A. ; Omar M.F.M. ; Soong R. ; Tan D.S.P.